Otsuka Pharmaceutical

Pharma

GSK's daprodustat will go before an FDA expert panel in October

Can GSK's daprodustat triumph in the U.S. where would-be AstraZeneca and Otsuka rivals stumbled? An FDA panel of outside experts will weigh in.
Fraiser Kansteiner Sep 6, 2022 3:55pm

Dupixent leads TV ad spending for 2nd month in a row

Jun 8, 2022 10:00am

Could the third time be the charm for an oral anemia med at FDA?

Apr 19, 2022 10:27am

Pharma TV ad spend in 2021: Goodbye Humira, hello Dupixent

Jan 20, 2022 9:35am

November sees Sanofi-Regeneron dethroned as top TV ad spender

Dec 5, 2021 7:30pm

Regeneron and Novo Nordisk hold tight at top for TV ad spending

Nov 9, 2021 3:35pm